login

Underreporting of suspected adverse drug reactions to newly marketed (“black triangle”) drugs in general practice: observational study

BMJPublished 11 July 1998Open access
Richard M. Martin, Ketan Kapoor, L. V. Wilton, Ronald D. Mann
Citations153
View PDF

TL;DR

The degree of underreporting of suspected adverse reactions to new drugs in general practice was assessed and if reporting varied when reactions were severe or previously unrecognised was determined.

Keywords

Economics, Econometrics and FinancePharmacology, Toxicology and PharmaceuticsHealth Professions